Long-term outcomes of different bortezomib-based regimens in Chinese myeloma patients.

about

Comparative analysis of the surgical treatment results for multiple myeloma bone disease of the spine and the long bone/soft tissue.Bortezomib-based therapy for transplant-ineligible East Asian patients with newly diagnosed mantle-cell lymphoma

P2860

Q55311492-397C1F62-7122-496C-9E15-27487E7A2800 Q57214849-AE647DA2-EBDB-4FFB-AFEF-FA3F80CB1674

P2860

Long-term outcomes of different bortezomib-based regimens in Chinese myeloma patients.

Item

http://www.wikidata.org/entity/Q36525841

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Long-term outcomes of different bortezomib-based regimens in Chinese myeloma patients.

@ast

Long-term outcomes of different bortezomib-based regimens in Chinese myeloma patients.

@en

type

Item

label

Long-term outcomes of different bortezomib-based regimens in Chinese myeloma patients.

@ast

Long-term outcomes of different bortezomib-based regimens in Chinese myeloma patients.

@en

prefLabel

Long-term outcomes of different bortezomib-based regimens in Chinese myeloma patients.

@ast

Long-term outcomes of different bortezomib-based regimens in Chinese myeloma patients.

@en

P1476

Long-term outcomes of different bortezomib-based regimens in Chinese myeloma patients.

@en

P2093

Hua Wang

http://www.w3.org/2001/XMLSchema#string

Liang Wang

http://www.w3.org/2001/XMLSchema#string

Qirong Geng

http://www.w3.org/2001/XMLSchema#string

Weida Wang

http://www.w3.org/2001/XMLSchema#string

Xiaoqin Chen

http://www.w3.org/2001/XMLSchema#string

Yue Lu

http://www.w3.org/2001/XMLSchema#string

Zhongjun Xia

http://www.w3.org/2001/XMLSchema#string

P2860

The choice of regimens based on bortezomib for patients with newly diagnosed multiple myeloma

Phase II PETHEMA trial of alternating bortezomib and dexamethasone as induction regimen before autologous stem-cell transplantation in younger patients with multiple myeloma: efficacy and clinical implications of tumor response kinetics.

Bortezomib as induction before autologous transplantation, followed by lenalidomide as consolidation-maintenance in untreated multiple myeloma patients.

Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study.

Bortezomib-thalidomide-based regimens improved clinical outcomes without increasing toxicity as induction treatment for untreated multiple myeloma: a meta-analysis of phase III randomized controlled trials.

Bortezomib in multiple myeloma: systematic review and clinical considerations.

Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma.

Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of an IFM phase II study.

The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myeloma.

Complete response correlates with long-term survival and progression-free survival in high-dose therapy in multiple myeloma.

P304

587-595

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S97457

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26869803

http://www.w3.org/2001/XMLSchema#string

P932

4734823

http://www.w3.org/2001/XMLSchema#string

Long-term outcomes of different bortezomib-based regimens in Chinese myeloma patients.

about

P2860

P2860

Long-term outcomes of different bortezomib-based regimens in Chinese myeloma patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932